- Home
- XNCR vs MCB Comparison
XNCR vs MCB Comparison
Compare XNCR & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- MCB
- Stock Information
- Founded
- XNCR 1997
- MCB 1999
- Country
- XNCR United States
- MCB United States
- Employees
- XNCR 250
- MCB N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- MCB Major Banks
- Sector
- XNCR Health Care
- MCB Finance
- Exchange
- XNCR Nasdaq
- MCB Nasdaq
- Market Cap
- XNCR 625.6M
- MCB 614.4M
- IPO Year
- XNCR 2013
- MCB 2017
- Fundamental
- Price
- XNCR $8.20
- MCB $66.89
- Analyst Decision
- XNCR Buy
- MCB Buy
- Analyst Count
- XNCR 9
- MCB 3
- Target Price
- XNCR $30.13
- MCB $76.33
- AVG Volume (30 Days)
- XNCR 970.6K
- MCB 118.8K
- Earning Date
- XNCR 05-07-2025
- MCB 04-21-2025
- Dividend Yield
- XNCR N/A
- MCB N/A
- EPS Growth
- XNCR N/A
- MCB N/A
- EPS
- XNCR N/A
- MCB 5.92
- Revenue
- XNCR $127,228,000.00
- MCB $270,555,000.00
- Revenue This Year
- XNCR N/A
- MCB $10.80
- Revenue Next Year
- XNCR $25.05
- MCB $11.86
- P/E Ratio
- XNCR N/A
- MCB $11.32
- Revenue Growth
- XNCR N/A
- MCB 12.84
- 52 Week Low
- XNCR $7.16
- MCB $37.10
- 52 Week High
- XNCR $27.24
- MCB $69.56
- Technical
- Relative Strength Index (RSI)
- XNCR 37.73
- MCB 69.07
- Support Level
- XNCR $7.89
- MCB $60.22
- Resistance Level
- XNCR $9.37
- MCB $68.75
- Average True Range (ATR)
- XNCR 0.83
- MCB 1.75
- MACD
- XNCR -0.13
- MCB 0.37
- Stochastic Oscillator
- XNCR 9.09
- MCB 78.19
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About MCB Metropolitan Bank Holding Corp.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.